Buprecare® 0.3mg/ml Solution Ampoules contain buprenorphine hydrochloride, a partial μ-opioid receptor agonist. This medication is used in veterinary medicine for pain management and sedation in cats and dogs.
Key Features
-
Active Ingredient: Contains buprenorphine hydrochloride, a partial μ-opioid receptor agonist.
-
Purpose: Primarily used for post-operative pain relief and sedation in cats and dogs.
-
Potentiation of Sedation: Enhances the sedative effects of centrally-acting agents in dogs.
-
Administration: Administered via injection (intravenous or intramuscular), ensuring rapid and effective action.
-
Controlled Drug: Classified as a Schedule 3 controlled drug under the Misuse of Drugs Regulations 2001 in the UK (requires secure storage and recording).Legal Category: POM-V (Prescription Only Medicine - Veterinarian), meaning it must be prescribed by a qualified veterinarian.
